Tilray Brands (TLRY) Other Non-Current Liabilities (2019 - 2026)
Tilray Brands (TLRY) reported Other Non-Current Liabilities of $164000.0 for Q1 2026, down 60.67% quarter-over-quarter from $417000.0 in Q4 2025.
Tilray Brands (TLRY) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Tilray Brands has reported Other Non-Current Liabilities for 8 years, with the latest figure at $164000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $164000.0; the trailing twelve-month figure through Feb 2026 stood at $164000.0 (changed N/A YoY), and the FY2025 full-year result was $855000.0, up 850.0% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $164000.0, down from $417000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $10.9 million in Q2 2023, with the low at $17000.0 in Q4 2024.
- Historically, Other Non-Current Liabilities has averaged $1.3 million across 5 years, with a median of $185000.0 in 2022.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities plunged 99.17% — and 2025, when it soared 2352.94%.
- Tilray Brands' Other Non-Current Liabilities stood at $185000.0 in 2022, then slumped by 60.0% to $74000.0 in 2023, then slumped by 77.03% to $17000.0 in 2024, then soared by 2352.94% to $417000.0 in 2025, then tumbled by 60.67% to $164000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $164000.0 (Q1 2026), $417000.0 (Q4 2025), and $855000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 164,000.00 |
| Nov 30, 2025 | 417,000.00 |
| May 31, 2025 | 855,000.00 |
| Nov 30, 2024 | 17,000.00 |
| Aug 31, 2024 | 99,000.00 |
| May 31, 2024 | 90,000.00 |
| Feb 29, 2024 | 210,000.00 |
| Aug 31, 2023 | 74,000.00 |
| May 31, 2023 | 10.89 Mn |
| Feb 28, 2023 | 3.34 Mn |
| Nov 30, 2022 | 185,000.00 |
| Aug 31, 2022 | 179,000.00 |
| Feb 28, 2022 | 292,000.00 |
| Nov 30, 2021 | 320,000.00 |
| Aug 31, 2021 | 4.51 Mn |
| May 31, 2021 | 3.91 Mn |
| Mar 31, 2020 | 5.42 Mn |
| Dec 31, 2019 | 5.65 Mn |
| Mar 31, 2019 | 563,000.00 |